JCI Expected to Weaken, MDKA to SCMA Stocks Recommended

The Jakarta Composite Index (JCI) is predicted to face a potential decline in today’s trading session, Tuesday (March 18, 2025). Several stocks, including MDKA, HMSP, and SCMA, are among the top investment picks.

Head of Research at Phintraco Sekuritas, Valdy Kurniawan, estimated that JCI’s resistance level stands at 6,630, with support around 6,370. “JCI is at risk of extending its decline to the 6,400-6,450 range today,” Valdy wrote in his research report on Tuesday (March 18, 2025).

According to data from the Indonesia Stock Exchange (IDX), JCI fell by 0.67% or 43.68 points, closing at 6,471.94 on Monday’s trading session (March 17, 2025). Year-to-date, the index has dropped by 8.59%.

External Factors and Positive Sentiment from China

On the external front, investors remain in a wait-and-see mode ahead of the Federal Open Market Committee (FOMC) meeting by the U.S. Federal Reserve on March 18-19, 2025. A poll conducted by CME FedWatch Tools indicates a 98% probability that the Fed will keep its benchmark interest rate steady at 4.25%-4.5% during the meeting.

Meanwhile, JCI could gain positive momentum from China’s latest policy aimed at boosting domestic consumption through the “Special Action Plan to Boost Consumption,” announced on March 16, 2025.

“This decision aligns with our view that China will continue to reduce its reliance on exports amid the ongoing tariff war with the U.S.,” Valdy stated.

He further noted that the policy could have a positive impact on Indonesia’s economy, given the country’s strong ties with China, particularly after joining BRICS.

For today’s trading session, Phintraco Sekuritas recommends stocks such as MDKA, HMSP, TINS, INCO, and SCMA.